<!DOCTYPE ArticleSet PUBLIC '-//NLM//DTD PubMed 2.8//EN' 'https://dtd.nlm.nih.gov/ncbi/pubmed/in/PubMed.dtd'>
<ArticleSet>
	<Article>
		<Journal>
			<PublisherName>International Rhinologic Society</PublisherName>
			<JournalTitle>Rhinology</JournalTitle>
			<Issn>0300-0729</Issn>
			<PubDate PubStatus='aheadofprint'>
				<Year>2025</Year>
				<Month>11</Month>
				<Day>30</Day>
			</PubDate>
		</Journal>
		<ArticleTitle>Web-application guided bimodal olfactory training for COVID-19 patients: a randomized trial</ArticleTitle>
		<Language>EN</Language>
		<AuthorList>
			<Author>
				<FirstName>C.</FirstName>
				<LastName>Vandersteen</LastName><AffiliationInfo><Affiliation>Institut Universitaire de la Face et du Cou, Centre Hospitalier Universitaire, UR2CA-REBOOT, Université Côte d’Azur, Nice, Alpes- Maritimes, France</Affiliation>
			</AffiliationInfo><AffiliationInfo><Affiliation>Université Côte d’Azur, laboratoire CoBTeK, Nice, Alpes-Maritimes, France</Affiliation>
			</AffiliationInfo>
			</Author>
			<Author>
				<FirstName>M.</FirstName>
				<LastName>Payne</LastName><AffiliationInfo><Affiliation>Université Côte d’Azur, laboratoire CoBTeK, Nice, Alpes-Maritimes, France</Affiliation>
			</AffiliationInfo><AffiliationInfo><Affiliation>Université Côte d’Azur, Département d’Orthophonie de Nice, UFR Médecine, Nice, Alpes-Maritimes, France</Affiliation>
			</AffiliationInfo>
			</Author>
			<Author>
				<FirstName>C.</FirstName>
				<LastName>Becker</LastName>
			<Affiliation>Givaudan Perfumery school Director, Argenteuil, France</Affiliation>
			</Author>
			<Author>
				<FirstName>S.</FirstName>
				<LastName>Bernier</LastName>
			<Affiliation>Institut NeuroMod, INRIA Centre de recherche Sophia Antipolis, Université Côte d’Azur, Sophia Antipolis, Alpes-Maritimes, France</Affiliation>
			</Author>
			<Author>
				<FirstName>A.</FirstName>
				<LastName>Derreumaux</LastName>
			<Affiliation>Université Côte d’Azur, laboratoire CoBTeK, Nice, Alpes-Maritimes, France</Affiliation>
			</Author>
			<Author>
				<FirstName>N.</FirstName>
				<LastName>Guevara</LastName>
			<Affiliation>Institut Universitaire de la Face et du Cou, Centre Hospitalier Universitaire, UR2CA-REBOOT, Université Côte d’Azur, Nice, Alpes- Maritimes, France</Affiliation>
			</Author>
			<Author>
				<FirstName>L.</FirstName>
				<LastName>Castillo</LastName>
			<Affiliation>Institut Universitaire de la Face et du Cou, Centre Hospitalier Universitaire, UR2CA-REBOOT, Université Côte d’Azur, Nice, Alpes- Maritimes, France</Affiliation>
			</Author>
			<Author>
				<FirstName>A.</FirstName>
				<LastName>Plonka</LastName><AffiliationInfo><Affiliation>Université Côte d’Azur, laboratoire CoBTeK, Nice, Alpes-Maritimes, France</Affiliation>
			</AffiliationInfo><AffiliationInfo><Affiliation>Institut NeuroMod, INRIA Centre de recherche Sophia Antipolis, Université Côte d’Azur, Sophia Antipolis, Alpes-Maritimes, France</Affiliation>
			</AffiliationInfo>
			</Author>
			<Author>
				<FirstName>V.</FirstName>
				<LastName>Manera</LastName><AffiliationInfo><Affiliation>Université Côte d’Azur, laboratoire CoBTeK, Nice, Alpes-Maritimes, France</Affiliation>
			</AffiliationInfo><AffiliationInfo><Affiliation>Université Côte d’Azur, Département d’Orthophonie de Nice, UFR Médecine, Nice, Alpes-Maritimes, France</Affiliation>
			</AffiliationInfo><AffiliationInfo><Affiliation>Institut NeuroMod, INRIA Centre de recherche Sophia Antipolis, Université Côte d’Azur, Sophia Antipolis, Alpes-Maritimes, France</Affiliation>
			</AffiliationInfo>
			</Author>
			<Author>
				<FirstName>X.</FirstName>
				<LastName>Fernandez</LastName>
			<Affiliation>Institut de Chimie de Nice, Université Nice Côte d’Azur, Nice, Alpes-Maritimes, France</Affiliation>
			</Author>
			<Author>
				<FirstName>A.</FirstName>
				<LastName>Gros</LastName><AffiliationInfo><Affiliation>Institut Universitaire de la Face et du Cou, Centre Hospitalier Universitaire, UR2CA-REBOOT, Université Côte d’Azur, Nice, Alpes- Maritimes, France</Affiliation>
			</AffiliationInfo><AffiliationInfo><Affiliation>Université Côte d’Azur, laboratoire CoBTeK, Nice, Alpes-Maritimes, France</Affiliation>
			</AffiliationInfo><AffiliationInfo><Affiliation>Université Côte d’Azur, Département d’Orthophonie de Nice, UFR Médecine, Nice, Alpes-Maritimes, France</Affiliation>
			</AffiliationInfo>
			</Author>
		</AuthorList>
<PublicationType>Journal Article</PublicationType>
		<ArticleIdList>
			<ArticleId IdType='pii'>3363</ArticleId>
			<ArticleId IdType='doi'>10.4193/Rhin24.273</ArticleId>
		</ArticleIdList>
		<Abstract>
	    	BACKGROUND: Many Post-Acute COVID-19 Syndrome (PACS) patients continue to experience persistent dysosmia up to two years post-pandemic. Cognitive and semantic memory functions, along with olfactory associative areas, may be affected in PACS without olfactory recovery. Visual-olfactory bimodal olfactory training may stimulate these areas. This study evaluates the olfactory recovery using a new bi-modal training kit, MaMadeleine™, assisted by a web application. METHODOLOGY: A prospective randomised study (Nov 2021–June 2022) included PACS patients aged ≥14 with post-infectious olfactory dysfunction. Patients were randomized for two months of simple (A) or semantic (B) visual-olfactory training. Evaluations included clinical assessments, Sniffin’ Sticks Tests, and quality-of-life questionnaires. Adherence to treatment was monitored via the web application. RESULTS: We
included 83 patients, on average 13±5.6 months after COVID-19. Olfactory training using MaMadeleine™ led to subjective orthoand retro-nasal olfactory improvement in 79.4% (n=58) and 58.9% (n=43) of patients, respectively, with Sniffin’ Sticks Test scores
increasing from 26.5±7.5 to 29.1±7.4. Both groups saw a 20% decrease in parosmia and phantosmia. No significant differences in recovery were observed between groups, although exploratory findings in a small subgroup (n=10) with semantic memory
impairment suggest a possible benefit of bimodal training, warranting further investigation. Quality of life improved significantly in both groups. Adherence was better in group B than in group A. CONCLUSIONS: MaMadeleine™ training improves subjective olfactory function, psychophysical test results, and quality of life in PACS patients with olfactory dysfunction. Multimodal training enhances adherence. Further studies are needed in semantic memory-impaired patients.
		</Abstract>
	</Article>
</ArticleSet>